Figure 3.
Forest plots of ORR between novel SA and CA stratified by phase. ORR in phase I trials in patients with R/R PTCL (A), ORR in phase II trials in patients with R/R PTCL (B), and ORR in phase II trials in patients with R/R CTCL (C). Forest plots are arranged in alphabetical order by author’s last name. Squares represent estimated proportions, with the size of the squares representing the weight of each trial according to the inverse variance method. Horizontal lines through the squares indicate 95% CIs. The points of the diamond indicate the 95% CI of the pooled mean. Horizontal line at the bottom indicates the prediction interval. Blank lines indicate missing information from the trial manuscript.

Forest plots of ORR between novel SA and CA stratified by phase. ORR in phase I trials in patients with R/R PTCL (A), ORR in phase II trials in patients with R/R PTCL (B), and ORR in phase II trials in patients with R/R CTCL (C). Forest plots are arranged in alphabetical order by author’s last name. Squares represent estimated proportions, with the size of the squares representing the weight of each trial according to the inverse variance method. Horizontal lines through the squares indicate 95% CIs. The points of the diamond indicate the 95% CI of the pooled mean. Horizontal line at the bottom indicates the prediction interval. Blank lines indicate missing information from the trial manuscript.

Close Modal

or Create an Account

Close Modal
Close Modal